What does expense ratio mean in ETF comparison?

The expense ratio is the annual fee charged by a fund, deducted from its assets. For example, BBH has an expense ratio of 0.35%, whereas IBB is 0.44%. This difference of 0.09 percentage points means that, over time, the higher fee can reduce potential returns if performance is otherwise equal. Investors should consider how fees impact long-term investment growth.

How do net assets influence ETF liquidity?

Net assets represent the total market value of a fund. BBH has $493 million in net assets, while IBB boasts $10.4 billion. Larger asset bases, like IBB's, often suggest better liquidity, as the fund can handle more trading volume without affecting its price. However, both funds offer exposure to the biotechnology sector.

What is dividend yield and why does it matter?

Dividend yield indicates how much income a fund pays relative to its price. BBH offers a 0.40% yield, while IBB provides 0.16%. While not all ETFs focus on income, understanding yields helps investors assess potential cash flow. Both funds primarily target growth within the biotechnology sector, with dividends as a secondary consideration.

What are the risks associated with smaller net assets?

BBH's smaller net assets of $493 million may present liquidity risks during high trading volumes or market stress. A fund with lower assets might see larger bid-ask spreads or difficulties executing large orders without affecting the price. In contrast, IBB's $10.4 billion assets potentially offer greater liquidity and stability, making it a more accessible choice for large investors.

What similarities exist in top holdings between BBH and IBB?

Both BBH and IBB feature significant overlap in their top holdings, including AMGN, GILD, VRTX, REGN, MRNA, NTRA, RVMD, ARGX, and ILMN. These shared companies are prominent players in the biotechnology sector. Such a high degree of overlap suggests both funds provide similar exposure to key biotech firms, reflecting comparable market views despite their differing fund structures.

What considerations are there regarding fees and investment returns?

BBH charges a 0.35% expense ratio, while IBB's is higher at 0.44%. Lower fees mean less impact on long-term returns, assuming identical performance, because a higher expense ratio reduces the total amount invested. Investors might find BBH appealing for its cost efficiency, though IBB's other factors may outweigh this consideration depending on an investor's overall strategy.

What sectors do BBH and IBB invest in?

Both BBH and IBB are categorized under Health, specifically focusing on the biotechnology sector. This sector involves companies engaged in the research, development, and production of biological products and services. While they track similar themes, each fund’s performance can vary due to different portfolio strategies, management styles, and market movements.

What is the inception significance of BBH and IBB?

BBH was launched on Dec 20, 2011, making it a relatively newer fund compared to IBB, which began on Feb 5, 2001. This means IBB has had over two decades to accumulate a broader historical track record. The longer inception date might provide IBB with more established performance data to evaluate against BBH, giving investors more confidence in its historical reliability.

How do ETF distributions work?

ETFs like BBH and IBB distribute income from dividends and interest earned on their underlying holdings to shareholders. BBH currently yields 0.40%, while IBB provides a smaller 0.16% yield. These distributions provide modest income opportunities. However, investors should remember that ETFs are typically designed for capital appreciation, and focusing solely on yields may not align with long-term goals.

What are the key educational takeaways for these ETFs?

Investors should understand that comparing ETFs requires evaluating multiple factors such as expense ratios, net assets, dividend yields, and top holdings. BBH and IBB show similar sector exposure but differ in cost efficiency and liquidity. Always remember that this comparison serves an educational purpose; it is not financial advice. Consider personal financial circumstances before investing.

BBH vs IBB

Two funds, one decision: we compare cost, performance and what each ETF actually holds in October 2026.

Compare VanEck Biotech ETF (BBH) and iShares Biotechnology ETF (IBB) side-by-side. Review expense ratios, net assets, dividend yields, and top holdings to understand how each fund tracks the biotech sector. Educational content, not financial advice.

Fund Snapshot

Key Fund Metrics

BBH

Metric

IBB

0.35%

Expense Ratio

0.44%

0.40%

Dividend Yield

0.16%

$493.35M

Net Assets

$10.45B

Holdings

249

Dec 20, 2011

Inception Date

Feb 5, 2001

–

Index Tracked

–

Health

Fund Category

Health

BBH costs about $9.00 less per year for every $10,000 invested.

Shared Top Holdings

Holding	BBH	IBB
AMGNAmgen Inc.	13.74%	7.31%
GILDGilead Sciences, Inc.	13.12%	8.37%
VRTXVertex Pharmaceuticals Incorporated	8.13%	7.61%
REGNRegeneron Pharmaceuticals, Inc.	6.76%	5.61%
MRNAModerna, Inc.	6.52%	4.06%
NTRANatera, Inc.	5.70%	3.59%
RVMDRevolution Medicines, Inc.	4.77%	2.66%
ARGXargenx SE	4.59%	3.97%
ILMNIllumina, Inc.	3.80%	2.60%

Investment Analysis

BBH

Pros

Lower expense ratio of 0.35% compared to the peer fund.
Higher dividend yield of 0.40% potentially offering modest income.
Concentrated top holdings in large-cap biotechnology leaders.

Considerations

Smaller net assets of $493 million may impact liquidity.
Index tracked information is not available for comparison.
Sector weight details are not available for analysis.

IBB

Pros

Larger net assets of $10.4 billion suggest strong liquidity.
Established history with an inception date of Feb 5, 2001.
Issuer iShares is a prominent fund manager.

Considerations

Higher expense ratio of 0.44% increases annual costs.
Lower dividend yield of 0.16% offers minimal income.
Index tracked and sector weight details are not available.

About BBH and IBB

BBH (BBH)

The VanEck Biotech ETF (BBH) offers investors exposure to the biotechnology sector, a key area within the broader health and life sciences industry. With a modest expense ratio of 0.35% and net assets of approximately USD 493 million, this fund holds a concentrated portfolio of 25 companies, aiming to track the performance of leading biotechnology firms. The fund has a low dividend yield of 0.40%, reflecting the sector’s focus on growth and innovation rather than income distribution. As biotechnology plays a crucial role in developing new treatments and technologies, BBH provides a way for investors to participate in these potential advancements. However, it is important to note that the biotech sector can be highly volatile due to regulatory hurdles, clinical trial outcomes, and market demand shifts. Investors should consider their risk tolerance and ensure this aligns with their overall investment strategy.

IBB (IBB)

The iShares Biotechnology ETF (IBB) offers investors diversified access to the dynamic biotechnology sector. As an exchange-traded fund, it tracks the performance of companies involved in medical research, drug development, and biotech innovation. With 249 holdings and net assets of USD 10.45 billion, IBB provides broad exposure to this capital-intensive industry. It carries an expense ratio of 0.44% and a modest dividend yield of 0.16%, reflecting the sector's focus on reinvestment for growth rather than income. Investors should note that biotechnology stocks can be highly volatile, driven by regulatory approvals and clinical trial outcomes. This ETF suits those seeking general exposure to healthcare innovation who understand that values can rise and fall significantly.

Buy BBH or IBB in Nemo

🆓

Zero Commission

Trade stocks, ETFs, and more with zero commission. Keep more of your returns.

🔒

Trusted & Regulated

Part of Exinity Group 2015, serving over a million customers globally.

💰

6% Interest on Cash

Earn 6% AER on uninvested cash with daily interest payments.

BBH vs IBB

Fund Snapshot

Investment Analysis

BBH

Pros

Considerations

IBB

Pros

Considerations

About BBH and IBB

Buy BBH or IBB in Nemo

Zero Commission

Trusted & Regulated

6% Interest on Cash

Frequently asked questions

What does expense ratio mean in ETF comparison?

How do net assets influence ETF liquidity?

What is dividend yield and why does it matter?

What are the risks associated with smaller net assets?

What similarities exist in top holdings between BBH and IBB?

What considerations are there regarding fees and investment returns?

What sectors do BBH and IBB invest in?

What is the inception significance of BBH and IBB?

How do ETF distributions work?

What are the key educational takeaways for these ETFs?

Fund Snapshot

About BBH and IBB